Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy

NCT01059461 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hypoxic-Ischemic Encephalopathy

Interventions

DRUG: Cerebrolysin®

Sponsor

Sahar M.A. Hassanein, MD